These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9582616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system.
    Lissoni P, Malugani F, Malysheva O, Kozlov V, Laudon M, Conti A, Maestroni G.
    Neuro Endocrinol Lett; 2002 Aug; 23(4):341-4. PubMed ID: 12195238
    [Abstract] [Full Text] [Related]

  • 5. Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems.
    Lissoni P, Messina G, Brivio F, Rovelli F, Di Fede G, Mainini E, Veronese E.
    J Biol Regul Homeost Agents; 2005 Aug; 19(3-4):141-4. PubMed ID: 16602629
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptophol.
    Lissoni P, Pittalis S, Rovelli F, Zecchini S, Casati M, Tremolada M, Pelizzoni F.
    J Biol Regul Homeost Agents; 1996 Aug; 10(1):27-30. PubMed ID: 9049779
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone.
    Lissoni P, Rovelli F, Baiocco N, Tangini G, Fumagalli L.
    Anticancer Res; 2001 Aug; 21(1B):777-9. PubMed ID: 11299843
    [Abstract] [Full Text] [Related]

  • 9. Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patients.
    Lissoni P, Rovelli F, Giani L, Fumagalli L, Mandalà M.
    Nat Immun; 1998 Aug; 16(5-6):178-84. PubMed ID: 11061586
    [Abstract] [Full Text] [Related]

  • 10. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
    Motta E, Ostrowska Z, Kazibutowska Z, Paluch M, Płonka J, Gołba A.
    Psychiatr Pol; 2005 Aug; 39(3):469-79. PubMed ID: 16149757
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies.
    Lissoni P, Bolis S, Brivio F, Fumagalli L.
    Anticancer Res; 2000 Aug; 20(3B):2103-5. PubMed ID: 10928160
    [Abstract] [Full Text] [Related]

  • 16. Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus.
    Köller MD, Templ E, Riedl M, Clodi M, Wagner O, Smolen JS, Luger A.
    Ann Rheum Dis; 2004 Dec; 63(12):1677-80. PubMed ID: 15082470
    [Abstract] [Full Text] [Related]

  • 17. A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients.
    Lissoni P, Rovelli F, Brivio F, Fumagalli L, Brera G.
    In Vivo; 2008 Dec; 22(3):397-400. PubMed ID: 18610754
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuroendocrine features in extreme longevity.
    Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, Magri F.
    Exp Gerontol; 2008 Feb; 43(2):88-94. PubMed ID: 17764865
    [Abstract] [Full Text] [Related]

  • 20. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
    Lissoni P, Brivio F, Fumagalli L, Messina G, Secreto G, Romelli B, Fumagalli G, Rovelli F, Colciago M, Brera G.
    In Vivo; 2007 Feb; 21(4):647-50. PubMed ID: 17708360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.